HSPB6: A lipid-dependent molecular chaperone inhibits α-synuclein aggregation.
Biological sciences
Cell biology
Chemistry
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
20 Sep 2024
20 Sep 2024
Historique:
received:
03
05
2024
revised:
09
06
2024
accepted:
31
07
2024
medline:
17
9
2024
pubmed:
17
9
2024
entrez:
16
9
2024
Statut:
epublish
Résumé
The process of protein misfolding and aggregation is associated with various cytotoxic effects. Understanding how this phenomenon is regulated by the protein homeostasis system, however, is difficult, since it takes place through a complex non-linear network of coupled microscopic steps, including primary nucleation, fibril elongation, and secondary nucleation, which depend on environmental factors. To address this problem, we studied how the aggregation of α-synuclein, a protein associated with Parkinson's disease, is modulated by molecular chaperones and lipid membranes. We focused on small heat shock proteins (sHSPs/HSPBs), which interact with proteins and lipids and are upregulated during aging, a major risk factor for protein misfolding diseases. HSPBs act on different microscopic steps to prevent α-synuclein aggregation, with HSPB6 showing a lipid-dependent chaperone activity. Our findings provide an example of how HSPBs diversified their mechanisms of action to reach an efficient regulation of protein misfolding and aggregation within the complex cellular environment.
Identifiants
pubmed: 39280615
doi: 10.1016/j.isci.2024.110657
pii: S2589-0042(24)01882-0
pmc: PMC11402235
doi:
Types de publication
Journal Article
Langues
eng
Pagination
110657Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
M.V. is a founder of WaveBreak Therapeutics (formerly Wren Therapeutics).